Slide 1: First Quarter 2013 Earnings Release
Exhibit 99.1 First Quarter 2013 Earnings Release April 23, 2013
Slide 2: Agenda
Agenda 2 • IDEX Outlook • Q1 Financial Performance • Q1 Segment Performance • Fluid & Metering • Health & Science • Fire & Safety / Diversified • Guidance Update • Q&A IDEX PROPRIETARY & CONFIDENTIAL
Slide 3: Replay Information
Replay Information 3 • Dial toll–free: 855.859.2056 • International: 404.537.3406 • Conference ID: #26072848 • Log on to: www.idexcorp.com IDEX PROPRIETARY & CONFIDENTIAL
Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act
4 Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward- looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause th
Slide 5: IDEX Q1 Financial Performance
IDEX Q1 Financial Performance 5 Revenue EPS* Organic: 1% decline 12% growth Operating Margin* Free Cash Flow* 90 bps expansion 28% growth Q1 2013 FCF of $0.81 cents per share * Q1 2012 EPS/ OperatingMargin data adjusted for restructuring expenses($4.9M) Outstanding EPS, Operating Margins & FCF perfo
Slide 6: Fluid & Metering
Fluid & Metering 6 Orders Revenue Operating Margin* Organic: 3% decline Organic: 1% decline 50 bps expansion Q1 Sales Mix:Organic -1% Q1Summary: Excellent improvement in operating margins driven by productivity initiatives Acquisition 0% Backlog grew by $9 million in the quarter Orders were impacted
Slide 7: Health & Science
Health & Science 7 Orders Revenue Operating Margin* Organic: 2% decline Organic: 7% decline 40 bps expansion Q1 Sales Mix:Organic -7% Q1 Summary: Sequential orders showed broad-based growth Acquisition 7% Backlog grew by $6 million in the quarter Operating margins expanded 40 basis points on the str
Slide 8: Fire & Safety/Diversified
Fire & Safety/Diversified 8 Orders Revenue Operating Margin* Organic: 13% decline Organic: 7% growth 200 bps expansion Q1 Sales Mix:Organic 7% Q1 Summary: Op margins up 200 bps YOY and 110 sequentially Acquisition 0% Backlog grew by $5 million in the quarter Large dispensing replenishment order in Q
Slide 9: Outlook: 2013 Guidance Summary
Outlook: 2013 Guidance Summary 9 Q2 2013 • EPS estimate range: $0.73 – $0.75 • Organic revenue growth ~ 2 – 3% • Positive revenue impact from acquisition of ~ 3% • Operating margin ~ 19% FY 2013 • EPS estimate range: $2.85 – $2.95 – Low-to-mid single digit organic revenue growth – Positive revenue i
Slide 10: Q&A
10 Q&A IDEX PROPRIETARY & CONFIDENTIAL